07.29.26 -- STREAM Edition: The Cost Of Late Engagement — In AI, Regulatory, And Supply Chain

Early stakeholder involvement helps spot protocol and logistical misalignments before they become operational issues, strengthening RTSM readiness and reducing activation delays.

After seeing AI reduce setup time and change requests, Novo Nordisk’s Ibrahim Kamstrup-Akkaoui and his team expanded AI’s use to automate documentation and medical coding, allowing staff to focus on complex work while improving efficiency and quality.

Expert perspectives on IRB oversight, health literacy, and research ethics offer practical guidance to strengthen consent, protect participants, and align compliance with real-world research.

Patients often face invisible hurdles in research. Watch how Patient Liaison services can change the journey for participants, sites, and sponsors, making trials easier to join and stay in.

We know that functional outsourcing is vital to clinical development today. This is why we build relationships and communicate with you to develop effective solutions.

Find a supply automation value engine with intelligent automation and algorithms to analyze drug supply data and automatically adjust delivery quantities to each site based on data available in IRT.

You've heard it before; sponsors must engage FDA early when using AI in clinical development. Hilary Marston warns that late engagement can cause irreparable damage to your regulatory strategy.